ES8701188A1 - Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disodico - Google Patents

Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disodico

Info

Publication number
ES8701188A1
ES8701188A1 ES545899A ES545899A ES8701188A1 ES 8701188 A1 ES8701188 A1 ES 8701188A1 ES 545899 A ES545899 A ES 545899A ES 545899 A ES545899 A ES 545899A ES 8701188 A1 ES8701188 A1 ES 8701188A1
Authority
ES
Spain
Prior art keywords
diphosphonate
disodium
amino
propane
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES545899A
Other languages
English (en)
Spanish (es)
Other versions
ES545899A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Henkel AG and Co KGaA
Original Assignee
Ciba Geigy AG
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4263070&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8701188(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy AG, Henkel AG and Co KGaA filed Critical Ciba Geigy AG
Publication of ES8701188A1 publication Critical patent/ES8701188A1/es
Publication of ES545899A0 publication Critical patent/ES545899A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165—Esters of thiophosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES545899A 1984-08-06 1985-08-05 Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disodico Expired ES8701188A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH376884 1984-08-06

Publications (2)

Publication Number Publication Date
ES8701188A1 true ES8701188A1 (es) 1986-11-16
ES545899A0 ES545899A0 (es) 1986-11-16

Family

ID=4263070

Family Applications (2)

Application Number Title Priority Date Filing Date
ES545899A Expired ES8701188A1 (es) 1984-08-06 1985-08-05 Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disodico
ES555602A Expired ES8706707A1 (es) 1984-08-06 1986-06-02 Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disordico

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES555602A Expired ES8706707A1 (es) 1984-08-06 1986-06-02 Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disordico

Country Status (26)

Country Link
US (2) US4639338A (en, 2012)
EP (1) EP0177443B1 (en, 2012)
JP (1) JPS6143196A (en, 2012)
KR (1) KR940000817B1 (en, 2012)
AR (4) AR240832A1 (en, 2012)
AT (1) ATE47396T1 (en, 2012)
AU (1) AU591066B2 (en, 2012)
CA (1) CA1255694A (en, 2012)
CY (1) CY1570A (en, 2012)
DD (1) DD239597A5 (en, 2012)
DE (1) DE3573783D1 (en, 2012)
DK (1) DK167282B1 (en, 2012)
DO (1) DOP1990004769A (en, 2012)
ES (2) ES8701188A1 (en, 2012)
FI (1) FI79712C (en, 2012)
GR (1) GR851910B (en, 2012)
HK (1) HK42591A (en, 2012)
HU (1) HU193124B (en, 2012)
IE (1) IE58077B1 (en, 2012)
IL (1) IL75990A (en, 2012)
MX (1) MX9203373A (en, 2012)
NO (1) NO165401C (en, 2012)
PH (1) PH24854A (en, 2012)
PT (1) PT80916B (en, 2012)
SG (1) SG91390G (en, 2012)
ZA (1) ZA855892B (en, 2012)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664158A5 (fr) * 1984-07-18 1988-02-15 Symphar Sa Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant.
ES2039237T3 (es) * 1986-04-24 1993-09-16 Fujisawa Pharmaceutical Co., Ltd. Procedimiento para preparar nuevos compuestos de acido difosfonico.
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
US4963681A (en) * 1987-07-06 1990-10-16 Norwich Eaton Pharmaceuticals, Inc. Process for synthesis of aminomethylene phosphonoalkylphosphinates
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
US4922007A (en) * 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
TW237386B (en, 2012) 1992-04-15 1995-01-01 Ciba Geigy
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
JP3266395B2 (ja) * 1993-11-24 2002-03-18 富士写真フイルム株式会社 有機薬品の晶析方法
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
PT891979E (pt) * 1997-07-15 2005-02-28 Gador Sa Uma forma cristalina do mono-hidrato do sal monossodico do acido n,n-dimetil-3-amino-1-hidroxipropan-1,1-difosfonico e o procedimento para a sua preparacao
EP1702924A3 (en) * 1998-08-27 2007-07-18 Teva Pharmaceutical Industries Ltd Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
EP1107974B1 (en) 1998-08-27 2006-08-02 Teva Pharmaceutical Industries Ltd. Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
EP0998933A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
US6160165A (en) * 1998-12-10 2000-12-12 Aesgen, Inc. Method for preparation of disodium pamidronate
ATE238315T1 (de) * 1998-12-10 2003-05-15 Aesgen Inc Verfahren zur herstellung von dinatriumpamidronat
US6794536B1 (en) 1998-12-10 2004-09-21 Aesqen, Inc. Method for preparation of disodium pamidronate
US6315566B1 (en) 1999-05-18 2001-11-13 3M Innovative Properties Company Dental materials
US6143919A (en) * 1999-05-18 2000-11-07 3M Innovative Properties Company Polymerizable acidic compounds and methods of preparation
US6963008B2 (en) * 1999-07-19 2005-11-08 Teva Pharmaceutical Industries Ltd. Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
ES2153794B1 (es) * 1999-08-06 2001-10-16 Medichem Sa Procedimiento para la obtencion del acido 4-amino-1-hidroxibutiliden-1,1-bisfosfonico y de su sal monosodica trihidratada.
KR100343232B1 (ko) * 1999-12-10 2002-07-10 김재윤 결정성 파미드론산 이나트륨염 수화물과 그의 제조방법
EP1318818A4 (en) * 2000-09-18 2004-09-29 Faulding F H & Co Ltd Diphosphonate SOLUTIONS
CA2431515C (en) * 2001-01-23 2008-01-22 Gador S.A. Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition, and use thereof
EP1390044A4 (en) 2001-05-02 2005-03-23 Sicor Inc PAMIDRONATE DINATRIUM FOR INJECTION
CA2347330C (en) * 2001-05-10 2002-03-12 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
ITMI20012751A1 (it) * 2001-12-21 2003-06-21 Lyogen Ltd Sale monosodico dell'acido pamidronico e procedimento per la sua preparazione
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
BR0215413A (pt) * 2001-12-24 2004-12-14 Teva Pharma Formula dosada com um comprimido central de ingrediente ativo encapado em uma capa anular prensada de material em pó ou granulado e processo e conjunto de ferramentas para a sua produção
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
SI1596870T2 (sl) * 2002-12-20 2011-07-29 Hoffmann La Roche Formulacija z visokim odmerkom ibandronata
US20050119230A1 (en) * 2003-09-18 2005-06-02 Alexandra Glausch Pharmaceutical products comprising bisphosphonated
WO2005054260A1 (en) * 2003-12-04 2005-06-16 Mustafa Nevzat Ilac Sanayii A.S. Method for producing pure disodium pamidronate
DK2283825T3 (da) 2004-05-24 2022-06-27 Theramex Hq Uk Ltd Enterisk fast oral doseringsform af en bisfosfonat indeholdende et chelateringsmiddel
WO2008128056A1 (en) * 2004-10-08 2008-10-23 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
WO2007109585A2 (en) * 2006-03-17 2007-09-27 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods
US7358361B2 (en) * 2004-10-08 2008-04-15 The Board Of Trustees Of The University Of Illinois Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
WO2008116133A1 (en) * 2007-03-21 2008-09-25 Duke University Medication kits and formulations for preventing, treating or reducing secondary fractures after previous fracture
CA2708281A1 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
PL2473172T3 (pl) 2009-09-01 2015-08-31 Univ Duke Kompozycje bisfosfonianowe i sposoby do leczenia niewydolności serca
FR2954320B1 (fr) 2009-12-17 2012-06-15 Cll Pharma Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels
AU2011239935A1 (en) 2010-04-16 2012-11-08 Novartis Ag Methods and compositions for improving implant osseointegration
CN104010647A (zh) 2011-11-16 2014-08-27 杜克大学 用于治疗和/或减轻心功能障碍的双膦酸盐组合物及方法
GB201200868D0 (en) 2012-01-19 2012-02-29 Depuy Int Ltd Bone filler composition
US11654152B2 (en) 2012-05-14 2023-05-23 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating disease
US20130303486A1 (en) * 2012-05-14 2013-11-14 Herriot Tabuteau Compositions Comprising Zoledronic Acid or Related Compounds for Relieving Pain Associated with Arthritis
KR101995432B1 (ko) * 2016-10-13 2019-07-02 엘지전자 주식회사 공기조화기 및 그 제어방법
EP3553067A1 (en) * 2018-04-10 2019-10-16 Abiogen Pharma S.p.A. Polymorph of sodium neridronate and preparation process thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130794C3 (de) * 1971-06-22 1974-07-11 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen Verfahren zur Herstellung von l-Hydroxy-S-amino-propan-ljl-diphosphonsäure
US4134969A (en) * 1974-02-04 1979-01-16 Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) Method of treatment of calcium disorders using aminoalkane-diphosphonic acids
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
DE2534391C2 (de) * 1975-08-01 1983-01-13 Henkel KGaA, 4000 Düsseldorf 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren
DE2553963A1 (de) * 1975-12-01 1977-06-08 Henkel & Cie Gmbh Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels
JPS5283957A (en) * 1975-12-01 1977-07-13 Henkel & Cie Gmbh Medicine for treating metabolic obstruction of calcium
SE7612534L (sv) * 1975-12-01 1977-06-02 Henkel & Cie Gmbh Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
SE409706B (sv) * 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
DE2702631A1 (de) * 1977-01-22 1978-07-27 Henkel Kgaa Verfahren zur herstellung von 1-hydroxy-3-amino-propan-1,1-diphosphonsaeuren
DE2943498C2 (de) * 1979-10-27 1983-01-27 Henkel KGaA, 4000 Düsseldorf Verfahren zur Herstellung von 3-Amino-1-hydroxypropan-1,1-diphosphonsäure
DE3016289A1 (de) * 1980-04-28 1981-10-29 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren
US4304734A (en) * 1980-10-16 1981-12-08 Vysoka Skola Chemicko-Technologicka 6-Amino-1-hydroxyhexylidene diphosphonic acid, salts and a process for production thereof
DE3151038A1 (de) * 1981-12-23 1983-07-28 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von 3-amino-1-hydroxypropan-1,1-diphosphonsaeure
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
CH664158A5 (fr) * 1984-07-18 1988-02-15 Symphar Sa Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
DK355485A (da) 1986-02-07
JPH058717B2 (en, 2012) 1993-02-02
ES8706707A1 (es) 1987-07-01
DE3573783D1 (en) 1989-11-23
PT80916B (pt) 1987-12-30
AU591066B2 (en) 1989-11-30
PT80916A (en) 1985-09-01
ES555602A0 (es) 1987-07-01
CA1255694A (en) 1989-06-13
IL75990A (en) 1989-07-31
ATE47396T1 (de) 1989-11-15
NO853087L (no) 1986-02-07
JPS6143196A (ja) 1986-03-01
ZA855892B (en) 1986-03-26
FI79712C (fi) 1990-02-12
HU193124B (en) 1987-08-28
NO165401C (no) 1991-02-06
IE851931L (en) 1986-02-06
AR240832A2 (es) 1991-02-28
DOP1990004769A (es) 1999-08-19
EP0177443B1 (de) 1989-10-18
HK42591A (en) 1991-06-07
US4639338A (en) 1987-01-27
DD239597A5 (de) 1986-10-01
SG91390G (en) 1991-01-18
AU4577785A (en) 1986-02-13
US4711880A (en) 1987-12-08
GR851910B (en, 2012) 1985-12-03
DK355485D0 (da) 1985-08-05
IE58077B1 (en) 1993-06-30
PH24854A (en) 1990-12-26
AR244698A1 (es) 1993-11-30
AR240832A1 (es) 1991-02-28
FI852986A0 (fi) 1985-08-02
AR244697A1 (es) 1993-11-30
NO165401B (no) 1990-10-29
HUT38361A (en) 1986-05-28
EP0177443A1 (de) 1986-04-09
AR244696A1 (es) 1993-11-30
KR940000817B1 (ko) 1994-02-02
FI852986L (fi) 1986-02-07
ES545899A0 (es) 1986-11-16
FI79712B (fi) 1989-10-31
MX9203373A (es) 1992-09-01
KR860001821A (ko) 1986-03-22
CY1570A (en) 1991-12-20
DK167282B1 (da) 1993-10-04

Similar Documents

Publication Publication Date Title
ES8701188A1 (es) Procedimiento para la obtencion de 3-amino-1-hidroxi-propan-1,1-difosfonato disodico
ES8704958A1 (es) Un metodo para preparar acido cicloalquil difosfonicos germinales sus sales y esteres.
ES8802428B9 (en) Pharmaceutical compositions containing geminal diphosphonates.
HUT35531A (en) Process for production of suitable for oral receiving, regulated medical preparatives of lasting influence
DZ854A1 (fr) Procédé continu de préparation d'acide phosphorique et de sulfate de calcium.
IT8349596A0 (it) Preparato medicinale per la cura dell'ulcera gastroduodenale
YU251183A (en) Process for making crystallised cephaemic acid's addition salts
FR2554809B1 (fr) Procede de preparation de l'acide acrylique
DE69129953D1 (de) Verwendung von Bisphosphonsäure zur Behandlung von Störungen des Kalziummetabolismus
BE895961A (fr) Procede de preparation d'un clone bacterien produisant de 1'alpha 1-antitrypsine humaine
EP0444000A3 (en) Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture
GB2039869B (en) Treatment of impure phosphoric acid
HUT49360A (en) Process for producing n-(phosphonomethyl)-iminodiacetic acid from the double salt of iminodiacetic acid
ES8307249A1 (es) Procedimiento de preparacion de nuevos derivados del adamantano.
DE3467705D1 (en) Use of 4,5'-azo-bis-salicylic acid for the manufacture of a medicament for the treatment of inflammatory disorders in the intestine
FR2558481B1 (fr) Procede de preparation de l'acide 4-amino-3-hydroxybutyrique optiquement actif
FR2619809B1 (fr) Procede de preparation d'acide fumarique pur
FR2575472B1 (fr) Procede de preparation d'hydrogeno- ou d'halogenosilanes
AU538311B2 (en) Treatment of disorders of calcium metabolism
FR2340905B1 (fr) Procede pour la production de phosphate bicalcique pour usage dans les mangeailles a partir de l'acide phosphorique et de la chaux
MA19776A1 (fr) Procede de defluoration de phosphates naturels ou artificiels
EP0289839A3 (en) Process for the purification of phosphorous acid
FR2529187B2 (fr) Procede pour la production de phosphate bicalcique pour usage dans les mangeailles a partir de l'acide phosphorique et de la chaux
FR2543948B1 (fr) Procede de preparation de l'acide 1-naphtol-4-sulfonique
CS57590A2 (en) Method of dearsenization sludge's treatment from phosphoric thermic acid's production

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20060612